Skip to main content

Olmesartan Medoxomil and Hydrochlorothiazide

NDC 46708-151 · Alembic Pharmaceuticals Limited

Generic nameOlmesartan Medoxomil and Hydrochlorothiazide
Dosage formTABLET
RouteORAL
Active ingredient(s)OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE
Strength25; 40 mg/1; mg/1
Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
Marketing categoryANDA

Packages

46708-151-08 — 80 TABLET in 1 CARTON (46708-151-08)

46708-151-10 — 100 TABLET in 1 CARTON (46708-151-10)

46708-151-30 — 30 TABLET in 1 BOTTLE (46708-151-30)

46708-151-90 — 90 TABLET in 1 BOTTLE (46708-151-90)

46708-151-91 — 1000 TABLET in 1 BOTTLE (46708-151-91)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

43547-460 — candesartan cilexetil and hydrochlorothiazide, 43547-461 — candesartan cilexetil and hydrochlorothiazide, 46708-115 — Metoprolol Tartrate and Hydrochlorothiazide, 46708-116 — Metoprolol Tartrate and Hydrochlorothiazide, 46708-117 — Metoprolol Tartrate and Hydrochlorothiazide, 46708-131 — Olmesartan Medoxomil, 46708-132 — Olmesartan Medoxomil, 46708-133 — Olmesartan Medoxomil, 46708-149 — Olmesartan Medoxomil and Hydrochlorothiazide, 46708-150 — Olmesartan Medoxomil and Hydrochlorothiazide, 46708-209 — Telmisartan and Hydrochlorothiazide, 46708-210 — Telmisartan and Hydrochlorothiazide, 46708-211 — Telmisartan and Hydrochlorothiazide, 46708-212 — Amlodipine besylate and Olmesartran medoxomil, 46708-213 — Amlodipine besylate and Olmesartran medoxomil, 46708-214 — Amlodipine besylate and Olmesartran medoxomil, 46708-215 — Amlodipine besylate and Olmesartran medoxomil, 46708-438 — Hydrochlorothiazide, 46708-442 — Irbesartan and Hydrochlorothiazide, 46708-443 — Irbesartan and Hydrochlorothiazide, +1040 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels